Practical Considerations for Adaptive Trial Design and Implementation -
- Format: Broché Voir le descriptif
Vous en avez un à vendre ?
Vendez-le-vôtre257,06 €
Produit Neuf
Ou 64,27 € /mois
- Livraison : 3,99 €
- Livré entre le 30 juillet et le 5 août
Nos autres offres
-
261,05 €
Produit Neuf
Ou 65,26 € /mois
- Livraison à 0,01 €
- Livré entre le 31 juillet et le 12 août
Brand new, In English, Fast shipping from London, UK; Tout neuf, en anglais, expédition rapide depuis Londres, Royaume-Uni;ria9781493955398_dbm
Voir le détail de l'annonce
- Payez directement sur Rakuten (CB, PayPal, 4xCB...)
- Récupérez le produit directement chez le vendeur
- Rakuten vous rembourse en cas de problème
Gratuit et sans engagement
Félicitations !
Nous sommes heureux de vous compter parmi nos membres du Club Rakuten !
TROUVER UN MAGASIN
Retour
Avis sur Practical Considerations For Adaptive Trial Design And Implementation de Format Broché - Livre Médecine, Pharmacie, Paramédical, Médecine vétérinaire
0 avis sur Practical Considerations For Adaptive Trial Design And Implementation de Format Broché - Livre Médecine, Pharmacie, Paramédical, Médecine vétérinaire
Les avis publiés font l'objet d'un contrôle automatisé de Rakuten.
-
Quantum Chemistry, 2nd Edition
1 avis
Neuf dès 199,48 €
-
The Lord Of The Rings
Neuf dès 183,21 €
-
Art Of Merit: Studies In Buddhist Art And Its Conservation
Neuf dès 284,14 €
-
Vouet: Grand Palais 6 Novembre 1990 11 Février 1991
Occasion dès 150,00 €
-
Paolo Roversi Livre Nudi
2 avis
Occasion dès 175,00 €
-
Imagine Too!
1 avis
Neuf dès 191,68 €
-
Seamanship In The Age Of Sail
Occasion dès 215,00 €
-
Gilbert Portanier
Neuf dès 141,34 €
-
Les Troubadours - Anthologie Bilingue - Jacques Roubaud
Occasion dès 130,00 €
-
Isles Of Gold: Antique Maps Of Japan
Occasion dès 174,99 €
-
Numicon: Homework Activities Intervention Resource - 'maths Bag' Of Resources Per Pupil
Neuf dès 154,00 €
-
Instruction Particuliere Et Secrete A Mon Fils: Oeuvres Spirituelles Classiques
Occasion dès 296,45 €
-
Winogrand Figments From The Real World
Occasion dès 170,99 €
-
Cryogenic Heat Transfer
Neuf dès 215,99 €
-
Genre In Archaic And Classical Greek Poetry: Theories And Models
Neuf dès 267,64 €
-
Very Similar
Neuf dès 131,99 €
-
Nuancier Dcs Cmyk Pro
Occasion dès 230,00 €
-
Dépression Et Anxiété : Comprendre Et Surmonter Par L'approche Cognitive
Occasion dès 163,95 €
-
L'ecole De Paris, 1945-1965: Dictionnaire Des Peintres (Dictionnaires)
2 avis
Occasion dès 166,41 €
-
Calvin Klein
Neuf dès 146,24 €
Produits similaires
Présentation Practical Considerations For Adaptive Trial Design And Implementation de Format Broché
- Livre Médecine, Pharmacie, Paramédical, Médecine vétérinaire
Résumé : Weili He is a Director and Senior Principle Scientist of Clinical Biostatistics at Merck & Co., Inc. She has a Ph.D. degree in biostatistics. She has extensive experience in drug development, and has worked in many therapeutic areas over the years. Dr. He has been active both at Merck and in industry for initiatives relating to adaptive trials, with particular focus on adaptive trial design and implementation.? She is a core member of the DIA Adaptive Design Scientific Working Group (ADSWG) and co-chair of the DIA ADSWG KOL Lecture series. Her research and collaboration with colleagues in various disciplines has led to over 30 publications in statistical and medical journals.??? Jos? Pinheiro has a Ph.D. in Statistics from the University of Wisconsin - Madison, having worked at Bell Labs and Novartis Pharmaceuticals, before his current position as Head of Statistical Modeling in the Model-Based Drug Development department at Janssen Research & Development. He has been involved in methodological development in various areas of statistics and drug development, including dose-finding, adaptive designs and mixed-effects models. He is a Fellow of the American Statistical Association, former co-chair of the PhRMA working group on Adaptive Dose-Ranging Studies, former core member of the PhRMA working group on Novel Adaptive Designs and co-developer of the nlme library/package in S-PLUS and R for linear and non-linear mixed-effects models. Olga Kuznetsova is a Senior Principal Scientist in the Late Development Statistics department of Merck & Co., Inc.?She has a PhD in probability theory and mathematical statistics and more than 15 years of experience in clinical trials. In the last decade, her research interests centered around randomization techniques in clinical trials, in particular, addressing the randomization needs of adaptive design trials. Her collaboration with colleagues on randomization issuesresulted in more than 20 presentations and publications.
Biographie: Weili He is a Director and Senior Principle Scientist of Clinical Biostatistics at Merck & Co., Inc. She has a Ph.D. degree in biostatistics. She has extensive experience in drug development, and has worked in many therapeutic areas over the years. Dr. He has been active both at Merck and in industry for initiatives relating to adaptive trials, with particular focus on adaptive trial design and implementation.? She is a core member of the DIA Adaptive Design Scientific Working Group (ADSWG) and co-chair of the DIA ADSWG KOL Lecture series. Her research and collaboration with colleagues in various disciplines has led to over 30 publications in statistical and medical journals.??? Jos? Pinheiro has a Ph.D. in Statistics from the University of Wisconsin - Madison, having worked at Bell Labs and Novartis Pharmaceuticals, before his current position as Head of Statistical Modeling in the Model-Based Drug Development department at Janssen Research & Development. He has been involved in methodological development in various areas of statistics and drug development, including dose-finding, adaptive designs and mixed-effects models. He is a Fellow of the American Statistical Association, former co-chair of the PhRMA working group on Adaptive Dose-Ranging Studies, former core member of the PhRMA working group on Novel Adaptive Designs and co-developer of the nlme library/package in S-PLUS and R for linear and non-linear mixed-effects models. Olga Kuznetsova is a Senior Principal Scientist in the Late Development Statistics department of Merck & Co., Inc.?She has a PhD in probability theory and mathematical statistics and more than 15 years of experience in clinical trials. In the last decade, her research interests centered around randomization techniques in clinical trials, in particular, addressing the randomization needs of adaptive design trials. Her collaboration with colleagues on randomization issuesresulted in more than 20 presentations and publications.
Sommaire:
..
Détails de conformité du produit
Personne responsable dans l'UE